Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 11744

1.

Three Huntington's Disease Specific Mutation-Carrying Human Embryonic Stem Cell Lines Have Stable Number of CAG Repeats upon In Vitro Differentiation into Cardiomyocytes.

Jacquet L, Neueder A, Földes G, Karagiannis P, Hobbs C, Jolinon N, Mioulane M, Sakai T, Harding SE, Ilic D.

PLoS One. 2015 May 20;10(5):e0126860. doi: 10.1371/journal.pone.0126860. eCollection 2015.

2.

Mediation of organismal aging and somatic proteostasis by the germline.

Khodakarami A, Saez I, Mels J, Vilchez D.

Front Mol Biosci. 2015 Jan 23;2:3. doi: 10.3389/fmolb.2015.00003. eCollection 2015. Review.

3.

Progression of behavioural despair in R6/2 and Hdh knock-in mouse models recapitulates depression in Huntington's disease.

Ciamei A, Detloff PJ, Morton AJ.

Behav Brain Res. 2015 May 15. pii: S0166-4328(15)00339-3. doi: 10.1016/j.bbr.2015.05.010. [Epub ahead of print]

PMID:
25986402
4.

Editorial: Programmatic Evaluation of HIV Prevention and Treatment in Nigeria.

Kanki PJ.

Curr HIV Res. 2015;13(3):174-5. No abstract available.

PMID:
25986367
5.

HTT/Huntingtin in Selective Autophagy and Huntington Disease: A foe or a friend within?

Rui YN, Xu Z, Patel B, Cuervo AM, Zhang S.

Autophagy. 2015 May 18:0. [Epub ahead of print] No abstract available.

PMID:
25985010
6.

Abnormalities in the tricarboxylic Acid cycle in huntington disease and in a huntington disease mouse model.

Naseri NN, Xu H, Bonica J, Vonsattel JP, Cortes EP, Park LC, Arjomand J, Gibson GE.

J Neuropathol Exp Neurol. 2015 Jun;74(6):527-37. doi: 10.1097/NEN.0000000000000197.

PMID:
25978848
7.

Evaluation of pyrrolidine and pyrazolone derivatives as inhibitors of trypanosomal phosphodiesterase B1 (TbrPDEB1).

Amata E, Bland ND, Campbell RK, Pollastri MP.

Tetrahedron Lett. 2015 May 20;56(21):2832-2835.

PMID:
25977593
8.

Neurodegenerative disorders: New Huntington disease target identified.

Crunkhorn S.

Nat Rev Drug Discov. 2015 May 15. doi: 10.1038/nrd4652. [Epub ahead of print] No abstract available.

PMID:
25976390
9.

Mitochondrial modulators in experimental Huntington's disease: reversal of mitochondrial dysfunctions and cognitive deficits.

Mehrotra A, Kanwal A, Banerjee SK, Sandhir R.

Neurobiol Aging. 2015 Jun;36(6):2186-200. doi: 10.1016/j.neurobiolaging.2015.02.004. Epub 2015 Feb 13.

PMID:
25976011
10.

Inhibition of MAP kinase/NF-kB mediated signaling and attenuation of lipopolysaccharide induced severe sepsis by cerium oxide nanoparticles.

Selvaraj V, Nepal N, Rogers S, Manne ND, Arvapalli R, Rice KM, Asano S, Fankhanel E, Ma JJ, Shokuhfar T, Maheshwari M, Blough ER.

Biomaterials. 2015 May 8;59:160-171. doi: 10.1016/j.biomaterials.2015.04.025. [Epub ahead of print]

PMID:
25968464
11.

Progressive cognitive deficit, motor impairment and striatal pathology in a transgenic huntington disease monkey model from infancy to adulthood.

Chan AW, Jiang J, Chen Y, Li C, Prucha MS, Hu Y, Chi T, Moran S, Rahim T, Li S, Li X, Zola SM, Testa CM, Mao H, Villalba R, Smith Y, Zhang X, Bachevalier J.

PLoS One. 2015 May 12;10(5):e0122335. doi: 10.1371/journal.pone.0122335. eCollection 2015.

12.

CYP2E1 epigenetic regulation in chronic, low-level toluene exposure: Relationship with oxidative stress and smoking habit.

Jiménez-Garza O, Baccarelli AA, Byun HM, Márquez-Gamiño S, Barrón-Vivanco BS, Albores A.

Toxicol Appl Pharmacol. 2015 May 9. pii: S0041-008X(15)00164-7. doi: 10.1016/j.taap.2015.04.016. [Epub ahead of print]

PMID:
25963742
13.

Ca<sup>2+</sup> Handling in Isolated Brain Mitochondria and Cultured Neurons Derived from the YAC128 Mouse Model of Huntington's Disease.

Pellman JJ, Hamilton J, Brustovetsky T, Brustovetsky N.

J Neurochem. 2015 May 12. doi: 10.1111/jnc.13165. [Epub ahead of print]

PMID:
25963273
14.

Substance use and treatment of substance use disorders in a community sample of transgender adults.

Keuroghlian AS, Reisner SL, White JM, Weiss RD.

Drug Alcohol Depend. 2015 Apr 22. pii: S0376-8716(15)00203-3. doi: 10.1016/j.drugalcdep.2015.04.008. [Epub ahead of print]

PMID:
25953644
15.

Iron accumulation in the basal ganglia in Huntington's disease: cross-sectional data from the IMAGE-HD study.

Domínguez D JF, Ng AC, Poudel G, Stout JC, Churchyard A, Chua P, Egan GF, Georgiou-Karistianis N.

J Neurol Neurosurg Psychiatry. 2015 May 7. pii: jnnp-2014-310183. doi: 10.1136/jnnp-2014-310183. [Epub ahead of print]

PMID:
25952334
16.

Huntingtin Is Required for Epithelial Polarity through RAB11A-Mediated Apical Trafficking of PAR3-aPKC.

Elias S, McGuire JR, Yu H, Humbert S.

PLoS Biol. 2015 May 5;13(5):e1002142. doi: 10.1371/journal.pbio.1002142. eCollection 2015 May.

17.

The Cambridge MRI database for animal models of Huntington disease.

Sawiak SJ, Morton AJ.

Neuroimage. 2015 May 2. pii: S1053-8119(15)00356-0. doi: 10.1016/j.neuroimage.2015.04.056. [Epub ahead of print]

PMID:
25941090
18.

A SNP in the HTT promoter alters NF-κB binding and is a bidirectional genetic modifier of Huntington disease.

Bečanović K, Nørremølle A, Neal SJ, Kay C, Collins JA, Arenillas D, Lilja T, Gaudenzi G, Manoharan S, Doty CN, Beck J, Lahiri N, Portales-Casamar E, Warby SC, Connolly C, De Souza RA; REGISTRY Investigators of the European Huntington's Disease Network, Tabrizi SJ, Hermanson O, Langbehn DR, Hayden MR, Wasserman WW, Leavitt BR.

Nat Neurosci. 2015 May 4. doi: 10.1038/nn.4014. [Epub ahead of print]

PMID:
25938884
19.

Sphingolipid metabolism correlates with cerebrospinal fluid Beta amyloid levels in Alzheimer's disease.

Fonteh AN, Ormseth C, Chiang J, Cipolla M, Arakaki X, Harrington MG.

PLoS One. 2015 May 4;10(5):e0125597. doi: 10.1371/journal.pone.0125597. eCollection 2015.

20.

Nocturnal agitation in Huntington disease is caused by arousal-related abnormal movements rather than by rapid eye movement sleep behavior disorder.

Neutel D, Tchikviladzé M, Charles P, Leu-Semenescu S, Roze E, Durr A, Arnulf I.

Sleep Med. 2015 Mar 3. pii: S1389-9457(15)00633-4. doi: 10.1016/j.sleep.2014.12.021. [Epub ahead of print]

PMID:
25934536
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk